IDH1 and acute myeloid leukemia: Cell line/primary blasts/in vivo (HL-60, MOLM14, NB4, 14 primary AML patient samples. A xenograft model based on immunodeficient NOD–scid IL2rγnull (NSG) mice with primary AML samples, or MOLM14 carrying the IDH1– R132H mutation).